Clinical Pharmacokinetics of Almotriptan, a Serotonin 5-HT 1B/1D Receptor Agonist for the Treatment of Migraine

Author： McEnroe Janet D.   Fleishaker Joseph C.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.44, Iss.3, 2005-01, pp. : 237-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rizatriptan: a new 5-HT1B/1D receptor agonist for the treatment of migraine

By Dahlof C.   Lines C.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 671-685

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine

By Bou J.   Domenech T.   Puig J.   Heredia A.   Gras J.   Fernandez-Forner D.   Beleta J.   Palacios J.M.  

European Journal of Pharmacology, Vol. 410, Iss. 1, 2000-12 ,pp. : 33-41

Elsevier

Access to resources Recommend Favorite

Cranial vascular effects of zolmitriptan, a centrally active 5-HT 1B/1D receptor partial agonist for the acute treatment of migraine

By MacLennan S.J.   Cambridge D.   Whiting M.V.   Marston C.   Martin G.R.  

European Journal of Pharmacology, Vol. 361, Iss. 2, 1998-11 ,pp. : 191-197

Elsevier

Access to resources Recommend Favorite

A review of rizatriptan, a quick and consistent 5-HT1B/1D agonist for the acute treatment of migraine

By Pascual Julio  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 669-677

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Tegaserod, a Serotonin 5-HT Receptor Partial Agonist with Promotile Activity

By Appel-Dingemanse S.  

Clinical Pharmacokinetics, Vol. 41, Iss. 13, 2002-01 ,pp. : 1021-1042

Adis International

Access to resources Recommend Favorite